American Oncology Network, Inc.
AONC · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,759,484 | $1,279,185 | $1,149,670 | $943,747 |
| % Growth | 37.5% | 11.3% | 21.8% | – |
| Cost of Goods Sold | $1,641,638 | $1,196,389 | $1,054,217 | $865,788 |
| Gross Profit | $117,846 | $82,796 | $95,453 | $77,959 |
| % Margin | 6.7% | 6.5% | 8.3% | 8.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $133,937 | $100,714 | $86,610 | $77,048 |
| SG&A Expenses | $133,937 | $100,714 | $86,610 | $77,048 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $1,338 | $31,236 | $3,277 | $0 |
| Operating Expenses | $135,275 | $131,950 | $89,887 | $77,048 |
| Operating Income | -$17,429 | -$49,154 | $5,566 | $911 |
| % Margin | -1% | -3.8% | 0.5% | 0.1% |
| Other Income/Exp. Net | $0 | -$13,353 | -$2,977 | -$556 |
| Pre-Tax Income | -$24,460 | -$62,507 | $2,589 | $355 |
| Tax Expense | $2,498 | $384 | $0 | $460 |
| Net Income | -$3,973 | -$5,542 | $2,589 | -$105 |
| % Margin | -0.2% | -0.4% | 0.2% | -0% |
| EPS | -0.69 | -1.36 | 0.062 | -0.003 |
| % Growth | 49.3% | -2,290% | 2,584% | – |
| EPS Diluted | -0.69 | -1.36 | 0.062 | -0.003 |
| Weighted Avg Shares Out | 13,717 | 6,686 | 41,688 | 41,688 |
| Weighted Avg Shares Out Dil | 13,491 | 6,686 | 41,688 | 41,688 |
| Supplemental Information | – | – | – | – |
| Interest Income | $3,199 | $1,326 | $151 | $127 |
| Interest Expense | $7,057 | $6,417 | $3,417 | $1,419 |
| Depreciation & Amortization | $19,371 | $16,739 | $17,083 | $6,079 |
| EBITDA | $1,815 | -$39,351 | $23,089 | $7,853 |
| % Margin | 0.1% | -3.1% | 2% | 0.8% |